Item 1A. RISK FACTORS

3K characters. Original on sec.gov · Markdown

Item 1A. RISK FACTORS

There have been no material changes in the company's risk factors from those disclosed in the company's Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on February 26, 2026.


Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Issuer Purchases of Equity Securities


Period	Total Number of Shares (or Units) Purchased (1)		Average Price Paid Per Share (or Unit)		Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs (1)	Maximum Number (or Approximate Dollar Value) of Shares (or Units) that May Yet Be Purchased Under the Plans or Programs (in millions) (1)
April 1 to April 30	740,654	(2)	$	291.64	740,623	$	1,983.8
May 1 to May 31	638,435	(3)	288.25		638,313	1,799.8
June 1 to June 30	1,167,853	(4)	253.14		1,167,348	1,504.4
Total	2,546,942	(5)			2,546,284

(1)CME Group maintains a share repurchase program under which CME Group is authorized to repurchase up to $3.0 billion of its outstanding Class A common stock, par value $0.01 per share (the common stock) as announced on December 5, 2024. The share repurchase program has no expiration date.

(2)Includes an aggregate of 31 shares of Class A common stock surrendered to satisfy employees' tax obligations upon the vesting of restricted stock.

(3)Includes an aggregate of 122 shares of Class A common stock surrendered to satisfy employee's tax obligations upon the vesting of restricted stock.

(4)Includes an aggregate of 505 shares of Class A common stock surrendered to satisfy employee's tax obligations upon the vesting of restricted stock.

(5)Shares purchased includes an aggregate of 658 shares of Class A common stock surrendered to satisfy employee tax obligations upon the vesting of restricted stock.

Previous: Item 4. CONTROLS AND PROCEDURES · Next: Item 5. OTHER INFORMATION